Filter
775
Text search:
pandemic
influenza
Featured
Recommendations
106
New Publications
81
Language
Document type
Guidelines
267
No document type
195
Studies & Reports
155
Manuals
54
Strategic & Response Plan
48
Fact sheets
28
Training Material
8
Situation Updates
8
Online Courses
4
Resource Platforms
3
Infographics
3
Brochures
1
Videos
1
Countries / Regions
Global
34
Brazil
29
Western and Central Europe
29
Latin America and the Carribbean
28
Russia
24
Germany
22
Eastern Europe and Central Asia
18
India
17
Middle East and North Africa
16
West and Central Africa
14
Sierra Leone
13
East and Southern Africa
13
Liberia
12
Syria
12
Africa
12
Ghana
11
South Africa
10
Mozambique
10
Kenya
8
Bangladesh
8
Angola
8
South–East Asia Region
8
Nepal
7
Yemen
7
Philippines
6
Ukraine
6
Vietnam
6
Nigeria
5
South Sudan
5
Western Pacific Region
5
Guinea
4
Guinea-Bissau
4
Rwanda
4
Ecuador
4
Laos
4
Portugal
4
USA
3
Ethiopia
3
Cambodia
3
Namibia
3
Peru
3
Colombia
3
Chile
3
Paraguay
3
Eastern Europe
3
Spain
3
Senegal
2
Cameroon
2
Uganda
2
Afghanistan
2
Zambia
2
Turkey
2
China
2
Indonesia
2
Sudan
2
Madagascar
2
Myanmar / Burma
2
Venezuela
2
Italy
2
Japan
2
Congo, Democratic Republic of
1
Mali
1
Somalia
1
Pakistan
1
Lebanon
1
Egypt
1
Mauritania
1
North Macedonia
1
Serbia
1
Botswana
1
Bolivia
1
Sri Lanka
1
Asia
1
Bhutan
1
Palestine
1
Armenia
1
Timor Leste/ East Timor
1
Tajikistan
1
Qatar
1
Uzbekistan
1
Kyrgyzstan
1
Kazakhstan
1
Georgia
1
Turkmenistan
1
France
1
Mauritius
1
United Kingdom
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
283
Public Health
39
Clinical Guidelines
33
Key Resources
20
Women & Child Health
13
Pharmacy & Technologies
12
Capacity Building
10
General Guidelines
1
Toolboxes
COVID-19
383
Rapid Response
120
Planetary Health
34
Ebola
29
AMR
22
Global Health Education
13
Refugee
10
Pharmacy
9
Health Financing Toolbox
8
NCDs
8
Conflict
7
HIV
7
TB
6
Specific Hazards
6
Natural Hazards
5
Zika
5
Mental Health
5
Cholera
3
Polio
3
Caregiver
3
NTDs
2
Disability
1
PlosOne https://doi.org/10.1371/journal.pone.0196799; Zoonotic diseases continue to be a public health burden globally. Uganda is especially vulnerable due to its location, biodiversity, and population. Given these concerns, the Ugandan government in collaboration with the Global Health Security Age
...
Despite the human and economic impact of viral epidemics, the world is not well enough prepared for the next emerging viral outbreak. Global trends indicate that new microbial threats will continue to emerge at an accelerating rate, driven by our growing population, expanded travel and trade network
...
Wet markets have been implicated in multiple zoonotic outbreaks, including COVID-19. They are also a conduit for legal and illegal trade in wildlife, which threatens thousands of species. Yet wet markets supply food to millions of people around the world, and differ drastically in their physical com
...
WBCSD Vision 2050 sets out the goal to achieve the highest attainable standard of health and wellbeing for everyone by 2050, calling for a world in which: people live healthy lives; societies promote and protect health; everyone has access to robust, resilient and sustainable healthcare services; an
...
Updated 2 June 2022.#
This entry contains the Status Report of WHO Collaborating Centres in the Americas by Country and a new document with information of Collaborating Centres by Outcome of the Strategic Plan of the Pan American Health Organization 2020‑2025.
Este informe presenta los resultados obtenidos de la evaluación de la efectividad de las vacunas contra la COVID-19 en Chile utilizando la red de vigilancia centinela de infecciones respiratorias agudas graves (IRAG). Los resultados que se presentan en este informe provienen de los datos proporcion
...
En Paraguay, la vacunación contra COVID-19 inició el 22 de febrero de 2021. Se han autorizado un total de siete vacunas: Bharat-Covaxin, Moderna, Pfizer-BioNTech, AstraZeneca, Sinopharm, Sputnik V- Gamaleya y CoronaVac-Sinovac. Los grupos prioritarios de vacunación están definidos según el Plan
...
This document aims to provide interim guidance for microbiology and virology experts, other laboratory professionals, laboratory managers, infectious disease programme managers, public health professionals and other stakeholders that provide primary, confirmatory or advanced testing for SARS-CoV-2,
...
first issued 18 August 2022
Der BAGSO-Ratgeber informiert kompakt und verständlich zu Impfungen für Erwachsene ab 60 Jahren. Er gibt Antworten auf zwölf häufig gestellte Fragen, u.a. für wen welche Impfungen besonders wichtig sind, wo man sich beraten lassen kann und ob die Kosten von der Krankenkasse übernommen werden.
...
The Event-based Surveillance Framework is intended to be used by authorities and agencies responsible for
surveillance and response. This framework serves as an outline to guide stakeholders interested in implementing
event-based surveillance (EBS) using a multisectoral, One Health approach. To
...
The reader acknowledges that this report is intended as an evidence-based asthma management strategy, for the use of health professionals and policy-makers. It is based, to the best of our knowledge, on current best evidence and medical knowledge and practice at the date of publication. When assessi
...
Mpox is an emerging zoonotic disease caused by the mpox virus, a member of the Orthopoxvirus genus closely related to the variola virus that causes smallpox. Mpox was first discovered in 1958 when outbreaks of a pox-like disease occurred in monkeys kept for research. The first human case was recorde
...
The document contains preliminary report on all aspects of WHO’s response in the Ebola outbreak. WHO Member States will discuss the report at the sixty-eighth World Health Assembly.
The report focuses on antibacterial resistance (ABR) in common bacterial pathogens. There is a major gap in knowledge about the magnitude of this problem. Antimicrobial resistance (AMR) threatens the effective revention and treatment of an ever-increasing range of infections caused by bacteria, para
...
